Reasons to get excited from the two interviews:
"A new beast in the field of cancer landscape. There is nothing like it. It covers the solid tumor with this CD19 marker. It has an opportunity to obliterate cancer types that haven't been touched before.
It potentially represents a paradigim shift in solid tumor treatment. It is a mark and kill approach and there is nothing like it.
We are involving major cancer centres in the US
It's revolutionary."
This was also just published:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-100
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.003(5.45%) |
Mkt cap ! $406.2M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.9¢ | 5.5¢ | $1.042M | 18.54M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 1046895 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 908887 | 13 |
View Market Depth
| Last trade - 15.39pm 25/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |